Form 4: Alignment Healthcare CEO John Kao Buys 103,000 Shares in Open Market

Sentiment:

SEC Form 4 Filing


Alignment Healthcare's CEO, John Kao, recently purchased 103,000 shares of the company's common stock in the open market.

Summary

  • On March 14, 2024, John E. Kao, the CEO of Alignment Healthcare, Inc., acquired 103,000 shares of common stock.
  • The purchase was made in the open market at a weighted-average price of $4.8231 per share.
  • The total number of shares beneficially owned by Mr. Kao following the transaction is 2,745,253 directly and 2,723,100 indirectly through the JEK Trust.
  • The shares were purchased at prices ranging from $4.77 to $4.87.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the CEO's significant stock purchase, which often signals confidence in the company's future performance. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

  • The CEO's purchase of a significant number of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive signal, suggesting that a company's management believes the stock is undervalued. It's a common practice among executives and board members.

Stakeholder Impact

  • The CEO's stock purchase could positively influence shareholder sentiment.

Key Dates

DateDescription
02/08/2021Date of JEK Trust
03/14/2024Date of the stock purchase transaction
03/18/2024Date of the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.